A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Thursday 21 November 2013

AstraZeneca: another reasoned order. Can you help?

Following today's earlier post with news of Case C-210/13 Glaxosmithline Biologicals SA, Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG v Comptroller-General of Patents, Designs and Trade Marks, The SPC Blog has been asked by a correspondent if we have a text for what appears to be another reasoned order of the Court of Justice of the European Union that was delivered on the same date in Case C-617/12 AstraZeneca AB v Comptroller-General of Patents. Again, the reasoned order does not appear to be accessible via the Curia website.

If any kind reader has a copy of this reasoned order which he or she is willing to share, do please get in touch!

1 comment:

Anonymous said...

Nothing found on curia, except that on calendar, C-443/12 Actavis and C-493/12 Eli Lilly are due to be delivered on 12/12/2013 it seems.